iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Q3FY24 Review: Torrent Pharmaceuticals: Steady performance across all parameters

5 Feb 2024 , 02:30 PM

Torrent Pharmaceuticals (Torrent)’s Q3 performance was steady across all fronts, with revenue growth of 12%/16% cc over the year-ago quarter in India/Brazil and EBITDA margin expansion of ~80 basis points sequentially to ~32%. With 40% organic expansion in India rep team over FY22-24, Torrent’s execution in new launches in the domestic market has been strong. This, along with scale-up in TGx and CHL portfolio, has allowed Torrent to outperform IPM volume growth. Brazil business has also benefited from 3-4 BGx launches p.a. over the past 3 years and Torrent is targeting to add new divisions of Derma/Oncology to its Brazil business over the next few years. 

With low-double-digit growth in India/Brazil business, US launches expected to pick-up from Q1FY25 and Balance Sheet deleveraging, analysts at IIFL Securities expect Torrent to deliver 13/22% EBITDA/EPS CAGR over FY24-27. They have tweaked their FY25/26 EPS estimates by 0-1% and have maintained their Buy rating on Torrent. Target Price of ₹2,840 (pegged at ~23x FY26 estimated EBITDA) implies 13% upside.

Related Tags

  • Torrent Pharmaceuticals
  • Torrent Pharmaceuticals Q3
sidebar mobile

BLOGS AND PERSONAL FINANCE

Images
15 Apr 2024   |   12:16 PM
Images
15 Apr 2024   |   10:33 AM
Images
15 Apr 2024   |   09:44 AM
Read More

Most Read News

15 Apr 2024   |   01:53 PM
15 Apr 2024   |   01:52 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

closeIcon

Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp